Renalytix Ai Stock Current Ratio

RNLX Stock  USD 0.16  0.01  6.67%   
Renalytix AI fundamentals help investors to digest information that contributes to Renalytix's financial success or failures. It also enables traders to predict the movement of Renalytix Stock. The fundamental analysis module provides a way to measure Renalytix's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Renalytix stock.
Last ReportedProjected for Next Year
Current Ratio 0.53  0.51 
Current Ratio is likely to drop to 0.51 in 2024.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Renalytix AI Company Current Ratio Analysis

Renalytix's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.

Current Ratio

 = 

Current Asset

Current Liabilities

More About Current Ratio | All Equity Analysis

Current Renalytix Current Ratio

    
  2.48 X  
Most of Renalytix's fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Renalytix AI is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Renalytix Current Ratio Driver Correlations

Understanding the fundamental principles of building solid financial models for Renalytix is extremely important. It helps to project a fair market value of Renalytix Stock properly, considering its historical fundamentals such as Current Ratio. Since Renalytix's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Renalytix's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Renalytix's interrelated accounts and indicators.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Competition

Renalytix Price To Sales Ratio

Price To Sales Ratio

11.26

At this time, Renalytix's Price To Sales Ratio is fairly stable compared to the past year.
In accordance with the recently published financial statements, Renalytix AI has a Current Ratio of 2.48 times. This is 14.78% lower than that of the Health Care Technology sector and significantly higher than that of the Health Care industry. The current ratio for all United States stocks is 14.81% lower than that of the firm.

Renalytix Current Ratio Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Renalytix's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Renalytix could also be used in its relative valuation, which is a method of valuing Renalytix by comparing valuation metrics of similar companies.
Renalytix is currently under evaluation in current ratio category among its peers.

Renalytix Fundamentals

About Renalytix Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Renalytix AI's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Renalytix using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Renalytix AI based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Renalytix Stock Analysis

When running Renalytix's price analysis, check to measure Renalytix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Renalytix is operating at the current time. Most of Renalytix's value examination focuses on studying past and present price action to predict the probability of Renalytix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Renalytix's price. Additionally, you may evaluate how the addition of Renalytix to your portfolios can decrease your overall portfolio volatility.